A Study of Changes in Heart Function and Blood Flow in People Receiving Anesthesia
Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Jul 13, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how general anesthesia affects heart function and blood flow during surgery. Researchers want to learn more about what happens to the heart in patients who experience low blood pressure after receiving anesthesia. By studying these changes, the goal is to improve safety and care for patients undergoing surgery with general anesthesia.
To participate in this study, you need to be an adult aged 18 or older who is scheduled for surgery that requires general anesthesia and intubation (a tube placed in your airway to help you breathe). You should have stable blood pressure before the surgery, with a specific measurement called mean arterial pressure (MAP) above 70 mmHg. However, if you have a history of heart problems, are taking certain medications for blood pressure, or are undergoing emergency surgery, you may not be eligible to join the trial. If you participate, you can expect to be closely monitored during and after your surgery to gather important information about how your heart is functioning with the anesthesia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients ≥ 18 years of age requiring general anesthesia for surgery
- • Intubation required for anesthetic management / surgery
- • Anticipated prep time before incision of 20 minutes
- • Baseline MAP \>70mmHg
- Exclusion Criteria:
- • History of coronary artery disease
- • History of cardiac disease (e.g., HTN, arrythmias, valvular and structural abnormalities)
- • History of peripheral artery occlusive disease
- • Beta-blocker use
- • Anti-hypertensive medication use
- • Patients with epidural, spinal, paravertebral, serratus blocks preoperatively
- • Patients requiring rapid sequence induction (where intubation occurs concurrently with induction)
- • Emergency surgery
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Anahita Dabo-Trubelja, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported